1 Anti-Infective Ophthalmic Market Overview 1.1 Product Overview and Scope of Anti-Infective Ophthalmic 1.2 Anti-Infective Ophthalmic Segment by Type 1.2.1 Global Anti-Infective Ophthalmic Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Antibacterial 1.2.3 Antiviral 1.2.4 Antifungal 1.2.5 Anti-Parasitic 1.2.6 Others 1.3 Anti-Infective Ophthalmic Segment by Application 1.3.1 Global Anti-Infective Ophthalmic Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Household 1.3.5 Others 1.4 Global Anti-Infective Ophthalmic Market Size Estimates and Forecasts 1.4.1 Global Anti-Infective Ophthalmic Revenue 2017-2028 1.4.2 Global Anti-Infective Ophthalmic Sales 2017-2028 1.4.3 Anti-Infective Ophthalmic Market Size by Region: 2017 Versus 2021 Versus 2028 2 Anti-Infective Ophthalmic Market Competition by Manufacturers 2.1 Global Anti-Infective Ophthalmic Sales Market Share by Manufacturers (2017-2022) 2.2 Global Anti-Infective Ophthalmic Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Anti-Infective Ophthalmic Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Anti-Infective Ophthalmic Manufacturing Sites, Area Served, Product Type 2.5 Anti-Infective Ophthalmic Market Competitive Situation and Trends 2.5.1 Anti-Infective Ophthalmic Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Anti-Infective Ophthalmic Players Market Share by Revenue 2.5.3 Global Anti-Infective Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Anti-Infective Ophthalmic Retrospective Market Scenario by Region 3.1 Global Anti-Infective Ophthalmic Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Anti-Infective Ophthalmic Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Anti-Infective Ophthalmic Market Facts & Figures by Country 3.3.1 North America Anti-Infective Ophthalmic Sales by Country 3.3.2 North America Anti-Infective Ophthalmic Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Anti-Infective Ophthalmic Market Facts & Figures by Country 3.4.1 Europe Anti-Infective Ophthalmic Sales by Country 3.4.2 Europe Anti-Infective Ophthalmic Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Anti-Infective Ophthalmic Market Facts & Figures by Region 3.5.1 Asia Pacific Anti-Infective Ophthalmic Sales by Region 3.5.2 Asia Pacific Anti-Infective Ophthalmic Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Anti-Infective Ophthalmic Market Facts & Figures by Country 3.6.1 Latin America Anti-Infective Ophthalmic Sales by Country 3.6.2 Latin America Anti-Infective Ophthalmic Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Anti-Infective Ophthalmic Market Facts & Figures by Country 3.7.1 Middle East and Africa Anti-Infective Ophthalmic Sales by Country 3.7.2 Middle East and Africa Anti-Infective Ophthalmic Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Anti-Infective Ophthalmic Historic Market Analysis by Type 4.1 Global Anti-Infective Ophthalmic Sales Market Share by Type (2017-2022) 4.2 Global Anti-Infective Ophthalmic Revenue Market Share by Type (2017-2022) 4.3 Global Anti-Infective Ophthalmic Price by Type (2017-2022) 5 Global Anti-Infective Ophthalmic Historic Market Analysis by Application 5.1 Global Anti-Infective Ophthalmic Sales Market Share by Application (2017-2022) 5.2 Global Anti-Infective Ophthalmic Revenue Market Share by Application (2017-2022) 5.3 Global Anti-Infective Ophthalmic Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Novartis 6.1.1 Novartis Corporation Information 6.1.2 Novartis Description and Business Overview 6.1.3 Novartis Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Novartis Anti-Infective Ophthalmic Product Portfolio 6.1.5 Novartis Recent Developments/Updates 6.2 Allergan 6.2.1 Allergan Corporation Information 6.2.2 Allergan Description and Business Overview 6.2.3 Allergan Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Allergan Anti-Infective Ophthalmic Product Portfolio 6.2.5 Allergan Recent Developments/Updates 6.3 Valeant Pharmaceuticals 6.3.1 Valeant Pharmaceuticals Corporation Information 6.3.2 Valeant Pharmaceuticals Description and Business Overview 6.3.3 Valeant Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Valeant Pharmaceuticals Anti-Infective Ophthalmic Product Portfolio 6.3.5 Valeant Pharmaceuticals Recent Developments/Updates 6.4 Santen Pharmaceutical 6.4.1 Santen Pharmaceutical Corporation Information 6.4.2 Santen Pharmaceutical Description and Business Overview 6.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Santen Pharmaceutical Anti-Infective Ophthalmic Product Portfolio 6.4.5 Santen Pharmaceutical Recent Developments/Updates 6.5 Lupin Pharmaceuticals 6.5.1 Lupin Pharmaceuticals Corporation Information 6.5.2 Lupin Pharmaceuticals Description and Business Overview 6.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Portfolio 6.5.5 Lupin Pharmaceuticals Recent Developments/Updates 6.6 Apotex 6.6.1 Apotex Corporation Information 6.6.2 Apotex Description and Business Overview 6.6.3 Apotex Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Apotex Anti-Infective Ophthalmic Product Portfolio 6.6.5 Apotex Recent Developments/Updates 6.7 Akorn 6.6.1 Akorn Corporation Information 6.6.2 Akorn Description and Business Overview 6.6.3 Akorn Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Akorn Anti-Infective Ophthalmic Product Portfolio 6.7.5 Akorn Recent Developments/Updates 7 Anti-Infective Ophthalmic Manufacturing Cost Analysis 7.1 Anti-Infective Ophthalmic Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Anti-Infective Ophthalmic 7.4 Anti-Infective Ophthalmic Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Anti-Infective Ophthalmic Distributors List 8.3 Anti-Infective Ophthalmic Customers 9 Anti-Infective Ophthalmic Market Dynamics 9.1 Anti-Infective Ophthalmic Industry Trends 9.2 Anti-Infective Ophthalmic Market Drivers 9.3 Anti-Infective Ophthalmic Market Challenges 9.4 Anti-Infective Ophthalmic Market Restraints 10 Global Market Forecast 10.1 Anti-Infective Ophthalmic Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Anti-Infective Ophthalmic by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Anti-Infective Ophthalmic by Type (2023-2028) 10.2 Anti-Infective Ophthalmic Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Anti-Infective Ophthalmic by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Anti-Infective Ophthalmic by Application (2023-2028) 10.3 Anti-Infective Ophthalmic Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Anti-Infective Ophthalmic by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Anti-Infective Ophthalmic by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Anti-Infective Ophthalmic Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Anti-Infective Ophthalmic Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Anti-Infective Ophthalmic Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Anti-Infective Ophthalmic Market Competitive Situation by Manufacturers in 2021 Table 5. Global Anti-Infective Ophthalmic Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Anti-Infective Ophthalmic Sales Market Share by Manufacturers (2017-2022) Table 7. Global Anti-Infective Ophthalmic Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Anti-Infective Ophthalmic Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Anti-Infective Ophthalmic Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Anti-Infective Ophthalmic Manufacturing Sites and Area Served Table 11. Manufacturers Anti-Infective Ophthalmic Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Anti-Infective Ophthalmic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Ophthalmic as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Anti-Infective Ophthalmic Sales by Region (2017-2022) & (K Units) Table 16. Global Anti-Infective Ophthalmic Sales Market Share by Region (2017-2022) Table 17. Global Anti-Infective Ophthalmic Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Anti-Infective Ophthalmic Revenue Market Share by Region (2017-2022) Table 19. North America Anti-Infective Ophthalmic Sales by Country (2017-2022) & (K Units) Table 20. North America Anti-Infective Ophthalmic Sales Market Share by Country (2017-2022) Table 21. North America Anti-Infective Ophthalmic Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Anti-Infective Ophthalmic Revenue Market Share by Country (2017-2022) Table 23. Europe Anti-Infective Ophthalmic Sales by Country (2017-2022) & (K Units) Table 24. Europe Anti-Infective Ophthalmic Sales Market Share by Country (2017-2022) Table 25. Europe Anti-Infective Ophthalmic Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Anti-Infective Ophthalmic Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Anti-Infective Ophthalmic Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Anti-Infective Ophthalmic Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Anti-Infective Ophthalmic Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Anti-Infective Ophthalmic Revenue Market Share by Region (2017-2022) Table 31. Latin America Anti-Infective Ophthalmic Sales by Country (2017-2022) & (K Units) Table 32. Latin America Anti-Infective Ophthalmic Sales Market Share by Country (2017-2022) Table 33. Latin America Anti-Infective Ophthalmic Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Anti-Infective Ophthalmic Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Anti-Infective Ophthalmic Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Anti-Infective Ophthalmic Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Anti-Infective Ophthalmic Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Anti-Infective Ophthalmic Revenue Market Share by Country (2017-2022) Table 39. Global Anti-Infective Ophthalmic Sales by Type (2017-2022) & (K Units) Table 40. Global Anti-Infective Ophthalmic Sales Market Share by Type (2017-2022) Table 41. Global Anti-Infective Ophthalmic Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Anti-Infective Ophthalmic Revenue Share by Type (2017-2022) Table 43. Global Anti-Infective Ophthalmic Price by Type (2017-2022) & (USD/Unit) Table 44. Global Anti-Infective Ophthalmic Sales (K Units) by Application (2017-2022) Table 45. Global Anti-Infective Ophthalmic Sales Market Share by Application (2017-2022) Table 46. Global Anti-Infective Ophthalmic Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Anti-Infective Ophthalmic Revenue Share by Application (2017-2022) Table 48. Global Anti-Infective Ophthalmic Price by Application (2017-2022) & (USD/Unit) Table 49. Novartis Corporation Information Table 50. Novartis Description and Business Overview Table 51. Novartis Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Novartis Anti-Infective Ophthalmic Product Table 53. Novartis Recent Developments/Updates Table 54. Allergan Corporation Information Table 55. Allergan Description and Business Overview Table 56. Allergan Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Allergan Anti-Infective Ophthalmic Product Table 58. Allergan Recent Developments/Updates Table 59. Valeant Pharmaceuticals Corporation Information Table 60. Valeant Pharmaceuticals Description and Business Overview Table 61. Valeant Pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Valeant Pharmaceuticals Anti-Infective Ophthalmic Product Table 63. Valeant Pharmaceuticals Recent Developments/Updates Table 64. Santen Pharmaceutical Corporation Information Table 65. Santen Pharmaceutical Description and Business Overview Table 66. Santen Pharmaceutical Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Santen Pharmaceutical Anti-Infective Ophthalmic Product Table 68. Santen Pharmaceutical Recent Developments/Updates Table 69. Lupin Pharmaceuticals Corporation Information Table 70. Lupin Pharmaceuticals Description and Business Overview Table 71. Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Table 73. Lupin Pharmaceuticals Recent Developments/Updates Table 74. Apotex Corporation Information Table 75. Apotex Description and Business Overview Table 76. Apotex Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Apotex Anti-Infective Ophthalmic Product Table 78. Apotex Recent Developments/Updates Table 79. Akorn Corporation Information Table 80. Akorn Description and Business Overview Table 81. Akorn Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Akorn Anti-Infective Ophthalmic Product Table 83. Akorn Recent Developments/Updates Table 84. Production Base and Market Concentration Rate of Raw Material Table 85. Key Suppliers of Raw Materials Table 86. Anti-Infective Ophthalmic Distributors List Table 87. Anti-Infective Ophthalmic Customers List Table 88. Anti-Infective Ophthalmic Market Trends Table 89. Anti-Infective Ophthalmic Market Drivers Table 90. Anti-Infective Ophthalmic Market Challenges Table 91. Anti-Infective Ophthalmic Market Restraints Table 92. Global Anti-Infective Ophthalmic Sales Forecast by Type (2023-2028) & (K Units) Table 93. Global Anti-Infective Ophthalmic Sales Market Share Forecast by Type (2023-2028) Table 94. Global Anti-Infective Ophthalmic Revenue Forecast by Type (2023-2028) & (US$ Million) Table 95. Global Anti-Infective Ophthalmic Revenue Market Share Forecast by Type (2023-2028) Table 96. Global Anti-Infective Ophthalmic Sales Forecast by Application (2023-2028) & (K Units) Table 97. Global Anti-Infective Ophthalmic Sales Market Share Forecast by Application (2023-2028) Table 98. Global Anti-Infective Ophthalmic Revenue Forecast by Application (2023-2028) & (US$ Million) Table 99. Global Anti-Infective Ophthalmic Revenue Market Share Forecast by Application (2023-2028) Table 100. Global Anti-Infective Ophthalmic Sales Forecast by Region (2023-2028) & (K Units) Table 101. Global Anti-Infective Ophthalmic Sales Market Share Forecast by Region (2023-2028) Table 102. Global Anti-Infective Ophthalmic Revenue Forecast by Region (2023-2028) & (US$ Million) Table 103. Global Anti-Infective Ophthalmic Revenue Market Share Forecast by Region (2023-2028) Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Anti-Infective Ophthalmic Figure 2. Global Anti-Infective Ophthalmic Market Share by Type in 2021 & 2028 Figure 3. Antibacterial Product Picture Figure 4. Antiviral Product Picture Figure 5. Antifungal Product Picture Figure 6. Anti-Parasitic Product Picture Figure 7. Others Product Picture Figure 8. Global Anti-Infective Ophthalmic Market Share by Application in 2021 & 2028 Figure 9. Hospital Figure 10. Clinic Figure 11. Household Figure 12. Others Figure 13. Global Anti-Infective Ophthalmic Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Anti-Infective Ophthalmic Market Size (2017-2028) & (US$ Million) Figure 15. Global Anti-Infective Ophthalmic Sales (2017-2028) & (K Units) Figure 16. Anti-Infective Ophthalmic Sales Share by Manufacturers in 2021 Figure 17. Global Anti-Infective Ophthalmic Revenue Share by Manufacturers in 2021 Figure 18. The Global 5 and 10 Largest Anti-Infective Ophthalmic Players: Market Share by Revenue in 2021 Figure 19. Anti-Infective Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 20. Global Anti-Infective Ophthalmic Sales Market Share by Region (2017-2022) Figure 21. Global Anti-Infective Ophthalmic Sales Market Share by Region in 2021 Figure 22. Global Anti-Infective Ophthalmic Revenue Market Share by Region (2017-2022) Figure 23. Global Anti-Infective Ophthalmic Revenue Market Share by Region in 2021 Figure 24. U.S. Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Canada Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Germany Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. France Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. U.K. Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Italy Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Russia Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. China Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Japan Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. South Korea Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. India Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Australia Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. China Taiwan Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Indonesia Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Thailand Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Malaysia Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Mexico Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Brazil Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Argentina Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Turkey Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Saudi Arabia Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. UAE Anti-Infective Ophthalmic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Sales Market Share of Anti-Infective Ophthalmic by Type (2017-2022) Figure 47. Manufacturing Cost Structure of Anti-Infective Ophthalmic Figure 48. Manufacturing Process Analysis of Anti-Infective Ophthalmic Figure 49. Anti-Infective Ophthalmic Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Novartis Allergan Valeant Pharmaceuticals Santen Pharmaceutical Lupin Pharmaceuticals Apotex Akorn